Literature DB >> 33264681

Coexistence of amyloidosis and light chain deposition disease in the heart.

Yoshihiro Sobue1, Genzou Takemura2, Shunji Kawamura3, Toshiyuki Yano4, Hiromitsu Kanamori5, Shin-Ichiro Morimoto6, Hitoshi Matsuo7.   

Abstract

There are few reports on the coexistence of cardiac amyloid light-chain (AL) amyloidosis and light chain deposition disease (LCDD), despite their similar pathophysiologies caused by plasma-cell dyscrasia. Herein, we report the coexistence of these diseases. A 59-year-old man was referred to our hospital because of exertional dyspnea and hypotension. Renal dysfunction of unknown etiology had been present for 4 years and hemodialysis had been introduced. Severe systolic and diastolic cardiac dysfunction was apparent, accompanied with dilatation and granular sparkling, but not with left ventricular hypertrophy. The plasma-free light chain κ was found to be extremely high, with a κ/λ ratio of 1,919. Light microscopic examination of the endomyocardial biopsy revealed spotty and homogenous deposits, which positively stained with Congo red, and exhibited a blazing apple-green color under polarized light. Based on these results, cardiac amyloidosis was diagnosed. In specimens prepared for electron microscopy, no amyloid fibrils could be found. Instead, we observed amorphous nonfibrillar deposits around several small vessels including capillaries and small arteries, which were consistent with light-chain deposits. LCDD was diagnosed based on the systemic increase in κ light chain and the ultrastructural findings of the endomyocardial biopsy specimens. Coexistence of cardiac amyloidosis and LCDD was thus confirmed in our patient. An electron microscopic assessment in addition to Congo red staining may be useful to diagnose latent LCDD in patients with suspected cardiac light-chain amyloidosis.
Copyright © 2020. Published by Elsevier Inc.

Entities:  

Keywords:  AL amyloidosis; Cardiomyopathy; cardiac amyloidosis; electron microscopy; endomyocardial biopsy; light chain deposition disease; ultrastructure

Mesh:

Substances:

Year:  2020        PMID: 33264681     DOI: 10.1016/j.carpath.2020.107315

Source DB:  PubMed          Journal:  Cardiovasc Pathol        ISSN: 1054-8807            Impact factor:   2.185


  2 in total

1.  A case of light chain deposition disease involving the kidney with a normal serum free kappa/lambda light chain ratio.

Authors:  Suojian Zhang; Haifeng Ni; Qin Xu; Xiaoqin Cai; Haitao Li; Zhiqiang Wei; Juan Cao
Journal:  Ren Fail       Date:  2022-12       Impact factor: 2.606

Review 2.  Randall-Type Monoclonal Immunoglobulin Deposition Disease: New Insights into the Pathogenesis, Diagnosis and Management.

Authors:  Camille Cohen; Florent Joly; Audrey Sibille; Vincent Javaugue; Estelle Desport; Jean-Michel Goujon; Guy Touchard; Jean-Paul Fermand; Christophe Sirac; Frank Bridoux
Journal:  Diagnostics (Basel)       Date:  2021-03-02
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.